Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jan

Showing results (191-200 of 255) with videos related to

Pageof 26
Sort By:
Cancer Immunology, Immunotherapy : CII|June 13, 2003
Lymphocyte subsets and T(h)1/T(h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcomeJohanna W van Sandick, Marja A Boermeester, Suzanne S Gisbertz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2005
Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancerHenderik L van Westreenen, Marinke Westerterp, Pieter L Jager, et al.
Annals of Surgery|August 14, 2024
Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde C G Overtoom, Ben M Eyck, Berend J van der Wilk, et al.
BMC Research Notes|April 6, 2017
Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samplesAnna M J van Nistelrooij, Ronald van Marion, Linetta B Koppert, et al.
Psycho-Oncology|January 30, 2009
Psychological factors and preferences for communicating prognosis in esophageal cancer patientsSanne J Franssen, Sjoerd M Lagarde, Jochem R van Werven, et al.
Annals of Surgery|December 24, 2002
Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancerJohanna W van Sandick, Suzanne S Gisbertz, Ineke J M ten Berge, et al.
World Journal of Microbiology & Biotechnology|November 16, 2019
Utilization of naproxen by Amycolatopsis sp. Poz 14 and detection of the enzymes involved in the degradation metabolic pathwayB M Alanis-Sánchez, S M Pérez-Tapia, S Vázquez-Leyva, et al.
Contemporary Clinical Trials Communications|June 7, 2022
Chemotherapy aNd chemoradiotherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trialCharlène J van der Zijden, Ben M Eyck, Ate van der Gaast, et al.
Annals of Surgery|November 29, 2007
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trialJikke M T Omloo, Sjoerd M Lagarde, Jan B F Hulscher, et al.
Journal of Clinical Pathology|September 28, 2010
Inter- and intraobserver variation in the histopathological evaluation of early oesophageal adenocarcinomaBrechtje A Grotenhuis, Mark van Heijl, Fiebo J W ten Kate, et al.
Pageof 26

Showing results (191-200 of 255) with videos related to

Sort By:
Pageof 26
Cancer Immunology, Immunotherapy : CII|June 13, 2003
Lymphocyte subsets and T(h)1/T(h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcomeJohanna W van Sandick, Marja A Boermeester, Suzanne S Gisbertz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2005
Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancerHenderik L van Westreenen, Marinke Westerterp, Pieter L Jager, et al.
Annals of Surgery|August 14, 2024
Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde C G Overtoom, Ben M Eyck, Berend J van der Wilk, et al.
BMC Research Notes|April 6, 2017
Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samplesAnna M J van Nistelrooij, Ronald van Marion, Linetta B Koppert, et al.
Psycho-Oncology|January 30, 2009
Psychological factors and preferences for communicating prognosis in esophageal cancer patientsSanne J Franssen, Sjoerd M Lagarde, Jochem R van Werven, et al.
Annals of Surgery|December 24, 2002
Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancerJohanna W van Sandick, Suzanne S Gisbertz, Ineke J M ten Berge, et al.
World Journal of Microbiology & Biotechnology|November 16, 2019
Utilization of naproxen by Amycolatopsis sp. Poz 14 and detection of the enzymes involved in the degradation metabolic pathwayB M Alanis-Sánchez, S M Pérez-Tapia, S Vázquez-Leyva, et al.
Contemporary Clinical Trials Communications|June 7, 2022
Chemotherapy aNd chemoradiotherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trialCharlène J van der Zijden, Ben M Eyck, Ate van der Gaast, et al.
Annals of Surgery|November 29, 2007
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trialJikke M T Omloo, Sjoerd M Lagarde, Jan B F Hulscher, et al.
Journal of Clinical Pathology|September 28, 2010
Inter- and intraobserver variation in the histopathological evaluation of early oesophageal adenocarcinomaBrechtje A Grotenhuis, Mark van Heijl, Fiebo J W ten Kate, et al.
Pageof 26